American HealthCare Capital is pleased to introduce a Closed Door Specialty pharmacy for sale in the Dallas, Texas area. This well-established pharmacy focuses on Developmentally Disabled pediatric patients. They service patients throughout the state of Texas.
The Pharmacy’s business is 100% Medicaid reimbursement. Payments are weekly with a DSO of no more than 9 days. Through August of 2017, the Pharmacy had gross revenues of $7,347,000 with a run rate of $11,000,000 through the end of the year. In 2016, gross revenue was $11,880,000. The drop in revenue began in May 2016 when Medicaid reduced its reimbursement, resulting in a decrease of approximately $80,000/month. Regardless, the Pharmacy net profit remains in the black, with an expected Adjusted EBITDA of $450,000 (4%) for 2017.
Beyond Texas, there is a growing market for pharmacies focused on heavily disabled children. Ownership will assist through a transition period, and the CEO/Pharmacist in Charge is willing to stay on in an executive capacity.
The asking price for this opportunity is $2.75 Million, plus the cost of inventory, which is estimated at $200,000.
